NICE u-turns on Celgene’s drug for multiple myeloma
November 24, 2016Medical Communications Celgene, NICE, imnovid
NICE has performed a U-turn on Celgene’s Imnovid (pomalidomide) based on new data and the offer of a price reduction. …
Woodley Equipment Exhibiting at Clinical Operations in Oncology Trials Europe
November 24, 2016clinical research, clinicaltrials, oncology
Woodley Equipment is exhibiting at Clinical Operations in Oncology Trials Europe, which is taking place on 29th and 30th November Steigenberger …
Non-small cell lung cancer market to hit $26bn by 2025
November 24, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GlobalData, non-small cell lung cancer
New research from GlobalData has indicated that the non-small cell lung cancer (NSCLC) market will rise in value by over …
Navidea agrees deal worth $310 million with Cardinal
November 24, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cardinal, Navidea, Navidea biopharmaceutical
Navidea Biopharmaceuticals, a developer of immunodiagnostic agents and immunotherapeutics, has announced that they will enter into a definitive asset purchase …
Patient deaths lead Juno Therapeutics to halt trial for second time
November 24, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acute lymphoblastic leukaemia, clinical trial deaths, juno therapeutics
Juno Therapeutics has been forced to halt a trial investigating the efficacy of its lead experimental CAR-T cancer treatment JCAR015 …
Lilly forced to abandon Alzheimer’s drug after failed trial
November 24, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Eli Lilly
Eli Lilly announced that the results of its ‘Expedition 3’ trial for an experimental Alzheimer’s disease drug meant that they would …
Allergan acquires Chase Pharma in potential $1 billion deal
November 23, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Allergan announced that it has completed the acquisition of Chase Pharmaceutical Corporation in a deal worth a potential $1 billion. …
Anthony Maddaluna, executive vice president of Pfizer, to retire
November 23, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Anthony J. Maddaluna, who worked at Pfizer for more than 41 years, will retire from his positions of executive vice …
Sun Pharma makes strategic Russian firm acquisition
November 23, 2016Research and Development, Sales and Marketing Biosintez, Russia, Sun Pharma
Sun Pharmaceutical, India’s largest pharmaceutical company, has acquired Russian pharmaceutical company JSC Biosintez in a total deal of $60 million. …
Pfizer set to develop new $200 million site
November 23, 2016Manufacturing and Production, Research and Development Pfizer, manufacturing and production
Pfizer plans to expand its operations in St. Louis, Missouri, by developing a $200 million facility in Chesterfield. The site …
Scientists identify an existing drug that could aid in therapy for brain swelling
November 23, 2016Medical Communications, Research and Development University of Arkansas, concussion, head injury
A team of biomedical engineering researches, who performed their study at the University of Arkansas, have identified a drug that …
University of Toronto develops circulating tumour cell monitoring tool
November 22, 2016Research and Development University of Toronto, circulating cancer cells
Researchers at the University of Toronto have developed a new tool which promises to enable the monitoring and profiling of …
Thomas Willemson promoted to China Area Head at GSK
November 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
GlaxoSmithKline appointed a new area head in Thomas Willemsen to take charge of its China drug business. He succeeds Herve …
J&J and Genmab’s drug races to second line treatment approval
November 22, 2016Manufacturing and Production, Research and Development, Sales and Marketing Genmab, Janssen, Johnson & Johnson, darzalex, multiple myeloma
Janssen, a part of Johnson & Johnson, and Genmab have announced that their multiple myeloma drug Darzalex (daratumumab) has been …
Mylan ducks call to testify in front of Senate
November 22, 2016Manufacturing and Production, Medical Communications Department of Justice, Mylan, epipen
Mylan has avoided the call to testify in front of the Senate judiciary committee. The hearing will be convened under …
Sanofi and Novo to face off in diabetes sphere following FDA approvals
November 22, 2016Manufacturing and Production, Sales and Marketing FDA, Novo Nordisk, Sanofi, Soliqua, Xultophy, diabetes
Sanofi and Novo are set to face off in the diabetes market after the FDA approved combination treatments from the …
AstraZeneca allowed to recruit for drug trial again
November 22, 2016Manufacturing and Production, Research and Development AstraZeneca, FDA, clinical trial
AstraZeneca’s clinical trial for head and neck cancer had previously been put on partial hold by the FDA due to …
Theresa May promises £2 billion a year in funding for R&D
November 21, 2016Manufacturing and Production, Medical Communications Conservative, Theresa May, brexit
The Conservative Party leader has announced a planned raise in funding for research and development for UK business to £2 …
Acorda forced to stop development of drug
November 21, 2016Manufacturing and Production, Research and Development Acorda therapeutics, clinical trial, post-stroke
Acorda Therapeutics announced that they were unable to continue development of the drug, dalfampridine, due to lack of efficacy in …
Pfizer sues Texas agency over leak of drug prices
November 21, 2016Medical Communications, Sales and Marketing Drug pricing, Pfizer, US, texas
Pfizer has sued Texas’ Health and Human Services Commission, after it claimed the agency violated state and federal law by …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
